Injective Releases New Whitepaper Focused on Institutional Finance and Tokenization

On October 7, Injective released a new version of its whitepaper, marking the first comprehensive rewrite since the original version was published in December 2018. The new version positions Injective as a Layer 1 solution aimed at institutional-grade finance and asset tokenization, covering the complete lifecycle of tokenized assets from issuance and trading to settlement. The whitepaper introduces a native RWA tokenization mechanism that allows for role-based permissions on minting, sending, receiving, and burning. iAssets provide derivatives that track external assets through stablecoin collateral and oracle pricing, without the need for wrapping or pre-funding. Tokenized assets are traded on a centralized limit order book across the entire chain, with each block utilizing a sealed high-frequency batch auction for uniform price settlement, protecting against front-running and transaction ordering MEV. BFT consensus provides deterministic finality with a block time of approximately 600 milliseconds. The new version also covers native EVM and WASM sharing the same state, perpetual contract risk management, and AI agent finance. Agents can operate tokenized assets through MCP servers, strategy-constrained signatures, and USDC-denominated x402 machine payment operations. On-chain protocol revenue will flow into regular INJ community buybacks.

This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.